Beta Bionics (BBNX) Change in Accured Expenses (2024 - 2026)

Beta Bionics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$5.2 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 1.06% year-over-year to -$5.2 million; the TTM figure through Mar 2026 stood at $7.5 million (up 316.48% YoY), while the FY2025 annual figure was $7.4 million, up 8.57% from the prior year.
• Change in Accured Expenses came in at -$5.2 million for Q1 2026 at Beta Bionics, down from $5.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.9 million in Q4 2025 to a low of -$5.3 million in Q1 2025.
• A 3-year average of $1.0 million and a median of $2.3 million in 2024 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 242.92% in 2025 and fell as far as 2182.68% in 2025.
• Beta Bionics' Change in Accured Expenses stood at $3.6 million in 2024, then surged by 64.16% to $5.9 million in 2025, then tumbled by 189.04% to -$5.2 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$5.2 million, $5.9 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison